Rhode Island Diastolic Dysfunction - Heart Failure

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Heart FailureCardiovascular Disease
Interventions
DRUG

Kuvan

Kuvan® (sapropterin dihydrochloride) will be initiated at 10mg/kg/day with meals for one week. After telephone contact on day 7, assuming no adverse effects are noted, the patient will be instructed to increase their daily dose to 20mg/kg/day with meals for the remainder of the 3 months.

Trial Locations (1)

02908

Providence VAMC, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
lead

Providence VA Medical Center

FED

collaborator

BioMarin Pharmaceutical

INDUSTRY

collaborator

Lifespan

OTHER